Stock Analiz

Charles River Laboratories International, Inc. (CRL) financials: revenue, earnings and cash flow

Fiscal 2016–2025 + TTM · from SEC filings · data as of November 16, 2026

Summary

Charles River Laboratories International’s revenue went from $1.7B in fiscal 2016 to $4.0B in fiscal 2025, growth of about 10.2% a year.

Net income in fiscal 2025 was -$144M, a net margin of -3.6%; the best year in this period was 2022 with $486M.

Over the twelve months to September 26, 2026, revenue was $4.0B and net income $40M.

Free cash flow was $518M in fiscal 2025 and positive in 10 of the 10 years shown.

The diluted share count rose 3% over the period (dilution).

Revenue, profit and cash flow by year

Revenue
2016: $1.7B162017: $1.9B172018: $2.3B182019: $2.6B192020: $2.9B202021: $3.5B212022: $4.0B222023: $4.1B232024: $4.0B242025: $4.0B25$4.0B
Net income
2016: $155M162017: $123M172018: $226M182019: $252M192020: $364M202021: $391M212022: $486M222023: $475M232024: $22M242025: -$144M25-$144M
Free cash flow
2016: $262M162017: $236M172018: $301M182019: $340M192020: $380M202021: $532M212022: $295M222023: $365M232024: $502M242025: $518M25$518M
EPS (diluted)
2016: $3.23162017: $2.54172018: $4.62182019: $5.07192020: $7.20202021: $7.60212022: $9.48222023: $9.22232024: $0.20242025: $-2.9125$-2.91

Income statement

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$4.0B$4.0B$4.0B$4.1B$4.0B$3.5B$2.9B$2.6B$2.3B$1.9B$1.7B
Gross profit—————————$1.6B$1.4B
Operating income$159M$25M$227M$617M$651M$590M$433M$351M$331M$288M$238M
Net income$40M-$144M$22M$475M$486M$391M$364M$252M$226M$123M$155M
EPS (diluted)$0.92$-2.91$0.20$9.22$9.48$7.60$7.20$5.07$4.62$2.54$3.23
R&D———————————
Revenue growth—−0.9%−1.9%+3.9%+12.3%+21.1%+11.6%+15.7%+22.0%+10.5%+23.3%

Cash flow

Fiscal yearTTM2025202420232022202120202019201820172016
Operating cash flow$622M$738M$735M$684M$620M$761M$547M$481M$441M$318M$317M
Capital spending-$223M-$219M-$233M-$319M-$325M-$229M-$167M-$141M-$140M-$82M-$55M
Free cash flow$400M$518M$502M$365M$295M$532M$380M$340M$301M$236M$262M
Dividends paid—$0$0$0$0$0$0$0$0$0$0
Buybacks$324M$361M$119M$24M$39M$41M$24M$18M$14M$107M$12M
Stock-based pay$81M$71M$70M$72M$74M$71M$56M$57M$47M$44M$44M

Balance sheet

Fiscal yearTTM2025202420232022202120202019201820172016
Cash—$214M$195M$277M$234M$242M$229M$239M$196M$192M$121M
Debt—$2.6B$2.8B$3.1B$3.1B$2.9B$2.2B$2.0B$1.8B$1.1B$1.2B
Equity—$3.2B$3.5B$3.6B$3.0B$2.5B$2.1B$1.6B$1.3B$1.0B$837M
Total assets—$7.1B$7.5B$8.2B$7.6B$7.0B$5.5B$4.7B$3.9B$2.9B$2.7B
Shares (diluted)49M50M52M51M51M51M51M50M49M49M48M

Margins and returns

Fiscal yearTTM2025202420232022202120202019201820172016
Gross margin—————————84.4%83.5%
Operating margin4.0%0.6%5.6%14.9%16.4%16.7%14.8%13.4%14.6%15.5%14.1%
Net margin1.0%-3.6%0.5%11.5%12.2%11.0%12.5%9.6%10.0%6.6%9.2%
FCF margin10.0%12.9%12.4%8.8%7.4%15.0%13.0%13.0%13.3%12.7%15.6%
ROIC—0.3%2.9%7.6%8.4%8.9%8.3%8.0%8.7%10.5%8.1%
ROE—-4.6%0.6%13.2%16.3%15.4%17.2%15.4%17.2%11.8%18.5%

Frequently asked questions

What is Charles River Laboratories International’s annual revenue?

$4.0B in fiscal 2025 and $4.0B over the twelve months to September 26, 2026.

How much profit does Charles River Laboratories International make?

Net income was -$144M in fiscal 2025 (net margin -3.6%).

Is Charles River Laboratories International’s revenue growing?

No: revenue fell 0.9% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.